GlassScriptPhysician profile
Sara Ghevariya
NPI 1578083929
$1,094.71
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $249 · 2023: $502 · 2024: $95.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.80 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $268.37 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $134.33 | 2021-2023 | Lo Loestrin Fe |
| Aspira Women'S Health INC | $74.33 | 2021-2022 | |
| Medtronic, INC. | $55.96 | 2023 | Interstim, V-Loc 180 |
| Cumberland Pharmaceuticals, INC. | $54.19 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.03 | 2023-2024 | Xifaxan |
| Exact Sciences Corporation | $43.78 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $39.41 | 2022 | |
| Axonics, INC. | $32.89 | 2021-2022 | |
| Agile Therapeutics, INC. | $32.34 | 2021-2023 | Twirla |
| Alydia Health | $32.25 | 2021 | |
| Exeltis, USA INC. | $31.09 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $29.91 | 2022 | |
| Scynexis, INC. | $28.97 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.91 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $24.35 | 2023 | Myfembree |
| Amgen INC. | $22.51 | 2023 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $21.43 | 2023 | |
| Avion Pharmaceuticals | $21.04 | 2022 | |
| Novo Nordisk INC | $19.41 | 2022 | |
| Biogen, INC. | $19.07 | 2024 | |
| Channel Medsystems, INC. | $18.64 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $15.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Ghevariya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.